Mirzotamab
CAS No. 2229859-11-2
Mirzotamab( —— )
Catalog No. M37129 CAS No. 2229859-11-2
Mirzotamab is an IgG1κ antibody targeting CD276/B7-H3 and is the naked antibody to Mirzotamab clezutoclax, consisting of 1320 amino acids.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 316 | Get Quote |
|
| 5MG | 534 | Get Quote |
|
| 10MG | 838 | Get Quote |
|
| 25MG | 1224 | Get Quote |
|
| 50MG | 1638 | Get Quote |
|
| 100MG | 2187 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMirzotamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionMirzotamab is an IgG1κ antibody targeting CD276/B7-H3 and is the naked antibody to Mirzotamab clezutoclax, consisting of 1320 amino acids.
-
DescriptionMirzotamab is an IgG1κ antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclax (HY-137774), an BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorImmunology/Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2229859-11-2
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tolcher A W, et al. A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results. 2021.
molnova catalog
related products
-
Indole-3-glyoxylamid...
Indole-3-glyoxylamide (3-Indoleglyoxamide) is a marine derived natural products found in Spongosorites sp.
-
2,6-Dibromo-4-(hydro...
2,6-Dibromo-4-(hydroxymethyl)phenol is a marine derived natural products found in Thelepus setosus.
-
Peptide C105Y
C105Y, a synthetic peptide (CSIPPEVKFNKPFVYLI) based on the amino acid sequence corresponding to residues 359-374 of alpha1-antitrypsin, enhances gene expression from DNA nanoparticles.
Cart
sales@molnova.com